1-3 of 3
Laura Moreno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

New Insights into the Mechanism of Action (MoA) of First-in-Class IgG-Based Bcma T-Cell Bispecific Antibody (TCB) for the Treatment of Multiple Myeloma (MM)

Laura Moreno, Aintzane Zabaleta, Diego Alignani, Marta Lasa, Patricia Maiso, PhD, Tomas Jelinek, MD, Victor Segura, PhD, Jose Antonio Delgado, Paula Rodriguez-Otero, MD PhD, Felipe Prosper, MD, Klaus Strein, MD PhD, Minh Diem Vu, PhD, Jesus San Miguel, MD PhD, Bruno Paiva, PhD
Journal: Blood
Blood (2016) 128 (22): 2096.
https://doi.org/10.1182/blood.V128.22.2096.2096
Published: 2016
Journal Articles

Critical Analysis on the Mechanism of Action (MoA) of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma (MM)

Laura Moreno, Aintzane Zabaleta, Diego Alignani, Daniel Ajona, Marta Lasa, Patricia Maiso, PhD, Tomas Jelinek, MD, Victor Segura, PhD, Jose Antonio Delgado, Paula Rodriguez-Otero, MD PhD, Felipe Prosper, MD, Jesus San Miguel, MD PhD, Bruno Paiva, PhD
Journal: Blood
Blood (2016) 128 (22): 2105.
https://doi.org/10.1182/blood.V128.22.2105.2105
Published: 2016
Journal Articles

Target Expression, Preclinical Activity and Mechanism of Action of EM801: A Novel First-in-Class Bcma T-Cell Bispecific Antibody for the Treatment of Multiple Myeloma

Anja Seckinger, MD, Jose Antonio Delgado, Laura Moreno, Brigitte Neuber, PhD, Anna Grab, PhD, Susanne Lipp, MS, Juana Merino, MDPhD, Minh Diem Vu, PhD, Klaus Strein, MD PhD, Felipe Prosper, MDPhD, Michael Hundemer, MD, Jesus San Miguel, MDPhD, Dirk Hose, MD, Bruno Paiva, PhD
Journal: Blood
Blood (2015) 126 (23): 117.
https://doi.org/10.1182/blood.V126.23.117.117
Published: 2015